Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
Database | Last Updated |
---|---|
ChEBI | February 3, 2022 |
KEGG | February 3, 2022 |
LIPID MAPS Structure Database | February 3, 2022 |
LipidBank | February 3, 2022 |
PubChem | February 3, 2022 |
Sub Class | LM ID | Common Name ▼ | LipidBank ID | KEGG ID | PubChem CID | ChEBI ID | Exact Mass | Formula |
---|---|---|---|---|---|---|---|---|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV B antigen(d18:1/26:0)
|
1837.070003
|
C88H160N2O37
|
|||||
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV B antigen(d18:1/24:1(15Z))
|
1807.023053
|
C86H154N2O37
|
|||||
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV B antigen(d18:1/24:0)
|
1809.038703
|
C86H156N2O37
|
|||||
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV B antigen(d18:1/22:0)
|
1781.007403
|
C84H152N2O37
|
|||||
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV B antigen(d18:1/20:0)
|
1752.976103
|
C82H148N2O37
|
|||||
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV B antigen(d18:1/18:0)
|
1724.944803
|
C80H144N2O37
|
|||||
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV B antigen(d18:1/16:0)
|
1696.913503
|
C78H140N2O37
|
|||||
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV B antigen
|
|||||||
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV A antigen(d18:1/26:1(17Z))
|
1876.080902
|
C90H161N3O37
|
|||||
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV A antigen(d18:1/26:0)
|
1878.096552
|
C90H163N3O37
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01